ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Phase 3 Study to Compare Upadacitinib to Abatacept in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease- Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs

ClinicalTrials.gov ID: NCT03086343

Public ClinicalTrials.gov record NCT03086343. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 1:01 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Active-Controlled, Double-Blind Study Comparing Upadacitinib (ABT-494) to Abatacept in Subjects With Moderately to Severely Active Rheumatoid Arthritis With Inadequate Response or Intolerance to Biologic DMARDs (bDMARDs) on Stable Conventional Synthetic Disease Modifying Anti-Rheumatic Drugs (csDMARDs)

Study identification

NCT ID
NCT03086343
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
657 participants

Conditions and interventions

Interventions

  • Abatacept Drug
  • Placebo for abatacept (0.9% Sodium Chloride Injection or Solution for Infusion) Drug
  • Placebo for upadacitinib Drug
  • Upadacitinib Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 8, 2017
Primary completion
Jun 12, 2019
Completion
Jun 5, 2023
Last update posted
Jul 17, 2024

2017 – 2023

United States locations

U.S. sites
44
U.S. states
22
U.S. cities
43
Facility City State ZIP Site status
SunValley Arthritis Center, Lt /ID# 154558 Peoria Arizona 85381
AZ Arthritis & Rheum Research /ID# 156539 Sun City Arizona 85351
AZ Arth & Rheum Res /ID# 167161 Tucson Arizona 85704
CHI St. Vincent Medical Group /ID# 154561 Hot Springs Arkansas 71913-6999
Saint Jude Heritage /ID# 158833 Fullerton California 92835
Kotha and Kotha /ID# 154573 La Mesa California 91942
Denver Arthritis Clinic /ID# 159195 Denver Colorado 80230
Arthritis and Rheum Clin N. CO /ID# 155673 Fort Collins Colorado 80528
Scientia Medical Research /ID# 159189 Lakewood Colorado 80228
Clinical Res of West FL, Inc. /ID# 154576 Clearwater Florida 33765
Advanced Clin Res of Orlando /ID# 154580 Ocoee Florida 34761-4547
Gulf Region Clinical Res Inst /ID# 154597 Pensacola Florida 32514
W. Broward Rheum Assoc Inc. /ID# 158835 Tamarac Florida 33321
Lovelace Scientific Resources /ID# 154600 Venice Florida 34292
Jefrey D. Lieberman, MD, P.C. /ID# 157178 Decatur Georgia 30033
Advanced Clinical Research /ID# 154603 Meridian Idaho 83642
PMG Research of Christie Clini /ID# 154569 Champaign Illinois 61820
Bluegrass Community Research /ID# 154604 Lexington Kentucky 40515
Four Rivers Clinical Research /ID# 154606 Paducah Kentucky 42003
Ochsner Clinic Foundation /ID# 154585 Baton Rouge Louisiana 70836-6455
The Center for Rheumatology & Bone Research /ID# 158723 Wheaton Maryland 20902
West Michigan Rheumatology /ID# 154551 Grand Rapids Michigan 49546
Advanced Rheumatology, PC /ID# 154589 Lansing Michigan 48910
Clinvest Research LLC /ID# 154554 Springfield Missouri 65810-2607
Overlook Medical Center /ID# 154794 Summit New Jersey 07901-3561
Atlantic Coast Research /ID# 155234 Toms River New Jersey 08755
Ocean Rheumatology, PA /ID# 162980 Toms River New Jersey 08755
Arthritis and Osteo Assoc /ID# 154560 Las Cruces New Mexico 88011
The Center for Rheumatology /ID# 162979 Albany New York 12206
NYU Langone Rheum Assoc /ID# 155236 Lake Success New York 11554
NYU Langone Medical Center /ID# 158829 New York New York 10016-6402
Physicians East, PA /ID# 154565 Greenville North Carolina 27834
PMG Research of Salisbury /ID# 154605 Salisbury North Carolina 28144
PMG Research of Wilmington LLC /ID# 154584 Wilmington North Carolina 28401
Wake Forest Baptist Medical Center /ID# 154586 Winston-Salem North Carolina 27157-0001
Oregon Health and Science University /ID# 163822 Portland Oregon 97239
East Penn Rheumatology Assoc /ID# 159193 Bethlehem Pennsylvania 18015
Altoona Ctr Clinical Res /ID# 154572 Duncansville Pennsylvania 16635
University of Pittsburgh MC /ID# 157434 Pittsburgh Pennsylvania 15260
West Tennessee Research Inst /ID# 158721 Jackson Tennessee 38305
Adriana Pop-Moody MD Clinic PA /ID# 154607 Corpus Christi Texas 78404
P&I Clinical Research /ID# 159191 Lufkin Texas 75904-3132
DM Clinical Research /ID# 158722 Tomball Texas 77375
Care Access Research /ID# 158098 Salt Lake City Utah 84124-1377

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 117 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03086343, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 17, 2024 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03086343 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →